Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less Than 12 Weeks in Chronological Age
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00485-15
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2015
Authors
Publisher
American Society for Microbiology